These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15959879

  • 1. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
    Ilkhanoff L, Lewis JD, Hennessy S, Berlin JA, Kimmel SE.
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
    [Abstract] [Full Text] [Related]

  • 2. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
    Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):985-90. PubMed ID: 15028354
    [Abstract] [Full Text] [Related]

  • 3. Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.
    Hochain P, Berkelmans I, Czernichow P, Duhamel C, Tranvouez JL, Lerebours E, Colin R.
    Eur J Gastroenterol Hepatol; 1995 May 17; 7(5):419-26. PubMed ID: 7614104
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
    Lewis JD, Kimmel SE, Localio AR, Metz DC, Farrar JT, Nessel L, Brensinger C, McGibney K, Strom BL.
    Gastroenterology; 2005 Dec 17; 129(6):1865-74. PubMed ID: 16344055
    [Abstract] [Full Text] [Related]

  • 6. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study.
    Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR.
    Lancet; 2002 Jan 12; 359(9301):118-23. PubMed ID: 11809254
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of medication recall using medication pictures and lists in telephone interviews.
    Kimmel SE, Lewis JD, Jaskowiak J, Kishel L, Hennessy S.
    Pharmacoepidemiol Drug Saf; 2003 Jan 12; 12(1):1-8. PubMed ID: 12622055
    [Abstract] [Full Text] [Related]

  • 8. Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure.
    Lewis JD, Strom BL, Kimmel SE, Farrar J, Metz DC, Brensinger C, Nessel L, Localio AR.
    Pharmacoepidemiol Drug Saf; 2006 Jan 12; 15(1):39-45. PubMed ID: 16136614
    [Abstract] [Full Text] [Related]

  • 9. Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs.
    Kelly JP, Coogan P, Strom BL, Rosenberg L.
    Pharmacoepidemiol Drug Saf; 2008 Apr 12; 17(4):322-7. PubMed ID: 18041807
    [Abstract] [Full Text] [Related]

  • 10. Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events.
    Cheng JW.
    Ann Pharmacother; 2006 Oct 12; 40(10):1785-96. PubMed ID: 16985093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E, Nedjar H, Bizzi A, Morin S.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1387-98. PubMed ID: 17892525
    [Abstract] [Full Text] [Related]

  • 13. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E, Nedjar H.
    Rheumatology (Oxford); 2007 Mar 15; 46(3):435-8. PubMed ID: 17255138
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
    Velentgas P, West W, Cannuscio CC, Watson DJ, Walker AM.
    Pharmacoepidemiol Drug Saf; 2006 Sep 15; 15(9):641-52. PubMed ID: 16392153
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study.
    Friis S, Poulsen AH, Sørensen HT, Tjønneland A, Overvad K, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.
    Cancer Causes Control; 2009 Jul 15; 20(5):731-40. PubMed ID: 19122977
    [Abstract] [Full Text] [Related]

  • 17. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.
    Helin-Salmivaara A, Virtanen A, Vesalainen R, Grönroos JM, Klaukka T, Idänpään-Heikkilä JE, Huupponen R.
    Eur Heart J; 2006 Jul 15; 27(14):1657-63. PubMed ID: 16731535
    [Abstract] [Full Text] [Related]

  • 18. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P, Celentano A, Palmieri V, Pezzullo S, Martino S, Bonito M, Guillaro B, Brancati C, Di Minno G.
    Nutr Metab Cardiovasc Dis; 2007 Jul 15; 17(6):468-72. PubMed ID: 17379491
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.
    García Rodríguez LA, Tacconelli S, Patrignani P.
    J Am Coll Cardiol; 2008 Nov 11; 52(20):1628-36. PubMed ID: 18992652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.